Pay in 4 interest-free payments of $5.24 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
FDA-approved alternatives like semaglutide (10-15% loss), tirzepatide (15-22% loss), and CagriSema (15-25% loss) offer comparable or superior results with proven long-term safety profiles, cardiovascular benefits rather than risks, and legal medical oversight
Is your Florida medical card expiring soon
When you create a caloric deficit, your body draws energy from both fat stores and muscle tissue
Wegovy primarily focuses on the GLP-1 receptor, while Zepbound targets multiple receptors (GLP-1, GIP, and glucagon), which may offer additional benefits for appetite suppression and energy expenditure
TRANSCEND-T2D-1 Type 2 diabetes (readout: March 19, 2026)
US$ 21.97
US$ 29.91
US$ 22.73
US$ 26.19
US$ 26.50
US$ 24.34
